Cargando…

Pharmacokinetics and Safety of the Selective Progesterone Receptor Modulator Vilaprisan in Chinese Healthy Postmenopausal Women

Vilaprisan is a novel selective progesterone receptor modulator for the long‐term treatment of uterine fibroids and endometriosis. This study investigated the pharmacokinetics, safety, and tolerability of vilaprisan in healthy Chinese postmenopausal women. Twelve participants received multiple doses...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Hongzhong, Jiang, Ji, Chen, Zhaozhao, Zhang, Yunhui, Li, Jinyi, Hoechel, Joachim, Rohde, Beate, Zimmermann, Torsten, Schultze‐Mosgau, Marcus‐Hillert
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8247050/ https://www.ncbi.nlm.nih.gov/pubmed/32716091 http://dx.doi.org/10.1002/cpdd.851

Ejemplares similares

Effect of Food Intake on the Pharmacokinetics of the Selective Progesterone Receptor Modulator Vilaprisan: A Randomized Clinical Study in Healthy Postmenopausal Women
por: Schultze‐Mosgau, Marcus‐Hillert, et al.
Publicado: (2020)

Effect of the Novel Selective Progesterone Receptor Modulator Vilaprisan on Ovarian Activity in Healthy Women
por: Schütt, Barbara, et al.
Publicado: (2017)

Clinical Pharmacokinetics and Pharmacodynamics of the Selective Progesterone Receptor Modulator Vilaprisan: A Comprehensive Overview
por: Schultze-Mosgau, Marcus-Hillert, et al.
Publicado: (2021)

The effects of vilaprisan on the pharmacodynamics and pharmacokinetics of a combined oral contraceptive—A randomized controlled trial
por: Schultze‐Mosgau, Marcus‐Hillert, et al.
Publicado: (2020)

Pharmacokinetics and Safety of the Novel Selective Progesterone Receptor Modulator Vilaprisan in Participants With Renal Impairment
por: Schultze‐Mosgau, Marcus‐Hillert, et al.
Publicado: (2020)

Characterization of the Pharmacokinetics of Vilaprisan: Bioavailability, Excretion, Biotransformation, and Drug–Drug Interaction Potential
por: Schultze-Mosgau, Marcus-Hillert, et al.
Publicado: (2018)

Effect of hepatic impairment on the pharmacokinetics of vilaprisan: An open‐label, single‐dose, parallel‐group study
por: Chattopadhyay, Niladri, et al.
Publicado: (2019)

Discovery of Vilaprisan (BAY 1002670): A Highly Potent and Selective Progesterone Receptor Modulator Optimized for Gynecologic Therapies
por: Möller, Carsten, et al.
Publicado: (2018)

Assessment of the safe and efficacious dose of the selective progesterone receptor modulator vilaprisan for the treatment of patients with uterine fibroids by exposure–response modelling and simulation
por: Sutter, Gabriele, et al.
Publicado: (2021)

The safety and pharmacokinetics of rapid iloprost aerosol delivery via the BREELIB nebulizer in pulmonary arterial hypertension
por: Gessler, Tobias, et al.
Publicado: (2017)

Ethnic comparison of pharmacokinetics of (18)F-florbetaben, a PET tracer for beta-amyloid imaging, in healthy Caucasian and Japanese subjects
por: Senda, Michio, et al.
Publicado: (2014)

Topical administration of regorafenib eye drops: phase I dose‐escalation study in healthy volunteers
por: Zimmermann, Torsten, et al.
Publicado: (2018)

Pharmacokinetics of hard micronized progesterone capsules via vaginal or oral route compared with soft micronized capsules in healthy postmenopausal women: a randomized open-label clinical study
por: Wang, Hanbi, et al.
Publicado: (2019)

Effect of Oral Semaglutide on the Pharmacokinetics of Levonorgestrel and Ethinylestradiol in Healthy Postmenopausal Women and Furosemide and Rosuvastatin in Healthy Subjects
por: Jordy, Andreas B., et al.
Publicado: (2021)

Pharmacokinetic Properties of Single- and Multiple-Dose Pitavastatin Calcium Tablets in Healthy Chinese Volunteers
por: Luo, Zhu, et al.
Publicado: (2015)

Absence of progesterone receptor associated with secondary breast cancer in postmenopausal women
por: Balleine, R L, et al.
Publicado: (1999)

Differential Effects of Estradiol and Progesterone on Cardiovascular Risk Factors in Postmenopausal Women
por: Roelfsema, Ferdinand, et al.
Publicado: (2018)

Association of Circulating Progesterone With Breast Cancer Risk Among Postmenopausal Women
por: Trabert, Britton, et al.
Publicado: (2020)

Pharmacokinetic Properties of Three Forms of Vaginal Progesterone Administered in Either Single Or Multiple Dose Regimen in Healthy Post-menopausal Chinese Women
por: Wu, Guolan, et al.
Publicado: (2017)

Quantitative Assessment of Levonorgestrel Binding Partner Interplay and Drug‐Drug Interactions Using Physiologically Based Pharmacokinetic Modeling
por: Cicali, Brian, et al.
Publicado: (2020)

In vivo TSPO imaging in patients with multiple sclerosis: a brain PET study with [(18)F]FEDAA1106
por: Takano, Akihiro, et al.
Publicado: (2013)

Possible significance of degeneration and decreased expression of progesterone receptor in postmenopausal uterine leiomyoma
por: Tanioka, Saki, et al.
Publicado: (2022)

Effects of Estradiol/Micronized Progesterone vs. Conjugated Equine Estrogens/Medroxyprogesterone Acetate on Breast Cancer Gene Expression in Healthy Postmenopausal Women
por: Lalitkumar, Parameswaran Grace Luther, et al.
Publicado: (2023)

Management of dental extraction in patients with Haemophilia A and B: A report of 58 extractions
por: Peisker, Andre, et al.
Publicado: (2014)

Progesterone Therapy, Endothelial Function and Cardiovascular Risk Factors: A 3-Month Randomized, Placebo-Controlled Trial in Healthy Early Postmenopausal Women
por: Prior, Jerilynn C., et al.
Publicado: (2014)

A phase 1/2, open-label, parallel group study to evaluate the safety and pharmacokinetics of DARE-HRT1 (80 μg estradiol/4 mg progesterone and 160 μg estradiol/8 mg progesterone intravaginal rings) over 12 weeks in healthy postmenopausal women
por: Thurman, Andrea, et al.
Publicado: (2023)

Influence of Fructooligosaccharide on Pharmacokinetics of Isoflavones in Postmenopausal Women
por: Teekachunhatean, Supanimit, et al.
Publicado: (2012)

Effect of Short-Course Oral Ciprofloxacin on Isoflavone Pharmacokinetics following Soy Milk Ingestion in Healthy Postmenopausal Women
por: Temyingyong, Nathathai, et al.
Publicado: (2019)

Postmenopausal Breast Cancer Risk in Relation to Antibodies Specific to Benzo[a]Pyrene, Estradiol and Progesterone
por: Glushkov, Andrew, et al.
Publicado: (2016)

SAT-440 Modulating Effects of Progesterone on Spontaneous and Ghrelin-Induced GH Secretion in Postmenopausal Women
por: Roelfsema, Ferdinand, et al.
Publicado: (2019)

Pharmacokinetics, Safety and Pharmacokinetics/Pharmacodynamics Analysis of Omadacycline in Chinese Healthy Subjects
por: Yang, Haijing, et al.
Publicado: (2022)

Pharmacokinetic, Pharmacokinetic/Pharmacodynamic, and Safety Investigations of Lefamulin in Healthy Chinese Subjects
por: Hu, Yingying, et al.
Publicado: (2023)

Serum levels of allopregnanolone, progesterone and testosterone in menstrually-related and postmenopausal migraine: A cross-sectional study
por: Rustichelli, Cecilia, et al.
Publicado: (2020)

Effects of combined 17β-estradiol and progesterone on weight and blood pressure in postmenopausal women of the REPLENISH trial
por: Black, Denise R., et al.
Publicado: (2020)

The Correlation Between Progesterone and Mammographic Density in Postmenopausal Women: A Systematic Review of the Literature and Meta-Analysis
por: Boutas, Ioannis, et al.
Publicado: (2023)

Characterisation of serum progesterone and progesterone-induced blocking factor (PIBF) levels across trimesters in healthy pregnant women
por: Lim, Mark Kit, et al.
Publicado: (2020)

Management of Dental Extraction in a Female Patient with Fanconi Anemia
por: Peisker, Andre, et al.
Publicado: (2014)

Orthognathic Surgery with Interdisciplinary Digital Planning in Patients with Geroderma Osteodysplasticum: A Case Report
por: Tolksdorf, Konrad, et al.
Publicado: (2023)

Ubiquitylomes Analysis of the Whole blood in Postmenopausal Osteoporosis Patients and healthy Postmenopausal Women
por: Yang, Yi‐ran, et al.
Publicado: (2019)

Progesterone for Acute Traumatic Brain Injury: A Systematic Review of Randomized Controlled Trials
por: Zeng, Yunhui, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_mm94tktgnvdavm72mnlpkrdhk7